Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Theravance Biopharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 123 | 1 | 119 | −3 |
| Shares | 64.1M | 57 | 62.1M | −2.01M (−3.1%) |
| Value | $649.8M | $1.00K | $696.1M | +$46.4M (+7.1%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Theravance Biopharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Irenic Capital Management LP | 1,700,937 | $19.1M | 10.13% |
| Saturn V Capital Management LLC | 141,339 | $1.33M | 1.11% |
| Palliser Capital (UK) Ltd | 97,100 | $1.09M | 2.65% |
| Tudor Investment Corp Et Al | 93,434 | $1.05M | 0.03% |
| Opaleye Management Inc. | 87,600 | $982.9K | 0.34% |
| Martingale Asset Management L P | 60,742 | $681.5K | 0.01% |
| Gsa Capital Partners LLP | 57,577 | $646.0K | 0.08% |
| Voloridge Investment Management, LLC | 45,813 | $514.0K | 0.00% |
| Occudo Quantitative Strategies LP | 43,321 | $486.1K | 0.06% |
| Schonfeld Strategic Advisors LLC | 29,160 | $327.2K | 0.00% |
| Trexquant Investment LP | 18,705 | $209.9K | 0.01% |
| Ameriprise Financial Inc | 16,430 | $185.0K | 0.00% |
| STRS Ohio | 16,300 | $182.0K | 0.00% |
| American Century Companies Inc | 12,698 | $142.5K | 0.00% |
| Verition Fund Management LLC | 11,261 | $126.3K | 0.00% |
| Point72 Middle East FZE | 3,649 | $40.9K | 0.00% |
| Gladius Capital Management LP | 3,553 | $39.9K | 0.01% |
| Global Retirement Partners, LLC | 300 | $3.37K | 0.00% |
Sold out (21)
Institutions that held Theravance Biopharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Rubric Capital Management LP | 356,100 | $3.61M |
| Bank of Montreal | 205,680 | $2.10M |
| Woodline Partners LP | 119,854 | $1.22M |
| Panagora Asset Management Inc | 103,049 | $1.04M |
| Brandywine Global Investment Management, LLC | 93,249 | $946.0K |
| Cannon Global Investment Management, LLC | 65,000 | $659.0K |
| Sagefield Capital LP | 51,600 | $523.0K |
| HRT Financial LP | 49,596 | $502.0K |
| Simplex Trading, LLC | 48,092 | $487.0K |
| Centiva Capital, LP | 41,300 | $419.0K |
| Boothbay Fund Management, LLC | 35,477 | $360.0K |
| Algert Global LLC | 30,700 | $311.0K |
| Leonteq Securities AG | 28,726 | $291.3K |
| XTX Topco Ltd | 20,410 | $207.0K |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 16,437 | $167.0K |
| CSS LLC | 15,000 | $153.0K |
| Canada Pension Plan Investment Board | 9,500 | $96.0K |
| Group One Trading, L.P. | 3,608 | $37.0K |
| Parallel Advisors, LLC | 215 | $2.00K |
| Crewe Advisors LLC | 131 | $1.00K |
| Bell Investment Advisors, Inc | 50 | $1.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Theravance Biopharma, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Pacific Center for Financial Services | 57 | $1.00K |